Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

3

Revenue 2017

MabThera/Rituxan

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. MabThera/Rituxan was produced by Roche.

Sandoz joins Europe's MabThera biosimilar push

Sandoz joins Europe's MabThera biosimilar push Novartis' Sandoz unit has become the second company to claim approval in Europe for a biosimilar version of Roche's blockbuster immunotherapy drug MabThera. ... MabThera is celebrating its 20th year on the market this year, and has been a massive earner

Payback time nears as Sanofi gets CHMP backing for biosimilar Humalog

Payback time nears as Sanofi gets CHMP backing for biosimilar Humalog The CHMP also backed three biosimilars of Roche's Rituxan (rituximab) developed by Celltrion namely Blitzima, Tuxella and Ritemvia.

WHO pilots scheme to make biosimilars available to poorer countries

WHO pilots scheme to make biosimilars available to poorer countries Plans to expand prequalification scheme to medicines such as Roche’s Rituxan and Herceptin. ... In the latest move the WHO says it will focus on biosimilar medicines, starting with Roche's widely-used cancer drugs MabThera/Rituxan (rituximab) and

A new decade of disruption: meeting the biosimilar challgenge

A new decade of disruption: meeting the biosimilar challgenge As the dust settles on the first ten years of disruption, the spotlight is now on the future as more leading MAbs, including Humira (adalimumab), MabThera (rituximab), Avastin (bevacizumab) and Lucentis

Mylan deal with Roche clears path to biosimilar Herceptin launch

Mylan deal with Roche clears path to biosimilar Herceptin launch Aside from Herceptin, and biosimilars of Roche's Avastin (bevacizumab) and Rituxan/MabThera (rituximab) are also starting to reach the market.

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics